Abnormal prothrombin (PIVKA-II) and hepatocellular carcinoma
Okuda, H.; Nakanish, T.; Furukawa, M.; Yamagata, H.; Obata, H.
Tropical Gastroenterology Official Journal of the Digestive Diseases Foundation 12(2): 59-66
1991
ISSN/ISBN: 0250-636X PMID: 1719681 Document Number: 386569
Document emailed within 1 workday
Related Documents
Fujiyama, S.; Morishita, T.; Sagara, K.; Sato, T.; Motohara, K.; Matsuda, I. 1986: Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma Hepato-Gastroenterology 33(5): 201-205Sakon, M.; Monden, M.; Gotoh, M.; Kobayashi, K.; Kanai, T.; Umeshita, K.; Endoh, W.; Mori, T. 1991: The effects of vitamin K on the generation of des-gamma-carboxy prothrombin (PIVKA-II) in patients with hepatocellular carcinoma American Journal of Gastroenterology 86(3): 339-345
Tanabe, Y.; Ohnishi, K.; Nomura, F.; Iida, S. 1988: Plasma abnormal prothrombin levels in patients with small hepatocellular carcinoma American Journal of Gastroenterology 83(12): 1386-1389
Sakurabayashi, I.; Kawai, T.; Omizo, R.; Hattori, N.; Ishii, M. 1988: Fundamental studies, reference values, and clinical evaluation of abnormal prothrombin PIVKA-II assay using monoclonal antibody (E-1023) Rinsho Byori. Japanese Journal of Clinical Pathology 36(12): 1407-1412
Ono, M.; Ohta, H.; Ohhira, M.; Sekiya, C.; Namiki, M. 1990: Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma American Journal of Gastroenterology 85(9): 1149-1154
Hasegawa, Y.; Tomita, K.; Hashimoto, K.; Shigeoka, Y.; Watanabe, M.; Yamasaki, A.; Shimizu, E. 2005: Des-gamma-carboxy prothrombin (PIVKA-II)-producing mediastinal embryonal carcinoma with features of hepatoid differentiation Anticancer Research 25(6c): 4569-4571
Koh, T.; Taniguchi, H.; Katoh, H.; Kunishima, S.; Yamaguchi, A.; Yamagishi, H. 2002: Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma? Hepato-Gastroenterology 49(48): 1615-1618
Yamashiki, M.; Kosaka, Y. 1989: Des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma Rinsho Byori. Japanese Journal of Clinical Pathology 37(2): 118-121
Laosombat, V.; Kenpitak, K.; Wongchanchailert, M.; Wiriyasateinkul, A. 1993: Acarboxy prothrombin (PIVKA-II) in cord plasma in the south of Thailand Journal of the Medical Association of Thailand 76(5): 278-284
Tsugawa, D.; Fukumoto, T.; Kido, M.; Takebe, A.; Tanaka, M.; Kuramitsu, K.; Matsumoto, I.; Ajiki, T.; Koyama, T.; Ku, Y. 2015: The Predictive Power of Serum α-Fetoprotein and Des-γ-Carboxy Prothrombin for Survival Varies by Tumor Size in Hepatocellular Carcinoma Kobe journal of medical sciences 61(5): E124-E131
Kawakita, T.; Shiraki, K.; Yamanaka, Y.; Yamaguchi, Y.; Saitou, Y.; Enokimura, N.; Yamamoto, N.; Okano, H.; Sugimoto, K.; Murata, K.; Yamakado, K.; Takeda, K.; Nakano, T. 2003: A new prognostic scoring system involving des-gamma-carboxy prothrombin as a useful marker for predicting prognosis in patients with hepatocellular carcinoma International Journal of Oncology 23(4): 1115-1120
Izuno, K.; Fujiyama, S.; Yamasaki, K.; Sato, M.; Sato, T. 1995: Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study Hepato-Gastroenterology 42(4): 387-393
Tang, W.; Miki, K.; Kokudo, N.; Sugawara, Y.; Imamura, H.; Minagawa, M.; Yuan, L-Wen.; Ohnishi, S.; Makuuchi, M. 2003: Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma International Journal of Oncology 22(5): 969-975
Kamijo, K.; Kawasaki, K.; Sato, M.; Yachi, A. 1989: Clinical studies on the relation of abnormal growth hormone secretions to hepatic diabetes mellitus in patients with hepatocellular carcinoma Gan no Rinsho. Japan Journal of Cancer Clinics 35(7): 775-779
Yao, D.-F.; Jiang, H.; Yao, M.; Li, Y.-M.; Gu, W.-J.; Shen, Y.-C.; Qiu, L.-W.; Wu, W.; Wu, X.-H.; Sai, W.-L. 2009: Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma Hepatobiliary and Pancreatic Diseases International: Hbpd Int 8(4): 407-413
Kamijo, K.; Kawasaki, K.; Sato, M.; Yachi, A. 1989: Clinical studies on the relation of abnormal growth hormone secretions to hepatic diabetes mellitus in patients with hepatocellular carcinoma Gan no Rinsho. Japan Journal of Cancer Clinics 35(7): 775-779
Kapp, P.; Bély, M.; Nemesánszky, E.; Szende, B. 2001: The role of perisinusoidal (Ito) cells in the course of hepatocellular carcinoma: light and electron microscopic data to the pathogenesis of hepatocellular carcinoma Orvosi Hetilap 142(49): 2741-2746
Zenali, M.J.; Tan, D.; Li, W.; Dhingra, S.; Brown, R.E. 2010: Stemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to conventional hepatocellular carcinoma Annals of Clinical and Laboratory Science 40(2): 126-134
Akahane, Y. 2001: Hepatocellular carcinoma in patients with parasitic liver disease--Japanese schistosomiasis and hepatocellular carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 474-477
Takeda, Y. 1970: Studies of the effects of heparin, Coumadin, and vitamin K on prothrombin metabolism and distribution in calves with the use of iodine-125-prothrombin. Characterization of the prothrombin system Journal of Laboratory and Clinical Medicine 75(3): 355-381